Middle Term Effect of Red Yeast Rice on Plasma Lipids and Proteoma in Individuals With Suboptimal Cholesterolemia - Trial NCT06368258
Access comprehensive clinical trial information for NCT06368258 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Bologna and is currently Not yet recruiting. The study focuses on Hypercholesterolemia. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Bologna
Timeline & Enrollment
N/A
May 02, 2024
May 02, 2025
Primary Outcome
Treatment-dependent change in LDL-C
Summary
The primary purpose of our research will be to evaluate if, in healthy subjects with a low-
 moderate cardiovascular risk (CV risk1% but 5%) evidenced by sub-optimal cholesterol
 levels as per ESC/EAS guidelines (LDL cholesterol 115 mg/dL, 190 mg/dL) supplementation
 with a red yeast rice food supplement containing less than 3 mg total monacolins per daily
 dose is able to significantly influence plasma lipid levels. Furthermore, liver and muscle
 proteomic pattern and vascular response to dietary supplementation will be investigated.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06368258
Non-Device Trial